治疗调节了对T细胞表位的反应,在结核病感染的谱中进行调节
Linda Petrone1, Daniela Peruzzu1, Anna Maria Gerarda Altera1
1Translational Research Unit, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy.
The Journal of infection
|September 29, 2024
概括
鉴定Mycobacterium结核病 (Mtb) 抗原是结核病 (TB) 疫苗的关键. 这项研究描述了对ATB116表位体的Mtb特异性免疫反应,发现它与结核病有关,并通过治疗调节.
科学领域:
- 免疫学 免疫学 免疫学
- 结核病研究 结核病研究
- 疫苗开发 疫苗开发
背景情况:
- 确定特定阶段的抗原对于开发有效的结核病 (TB) 诊断和疫苗至关重要.
- 这项研究的重点是鉴定Mycobacterium结核病 (Mtb) 特定的免疫反应对Mtb衍生表位组 (ATB116) 的特征.
- 这种表位组池以前被证明与结核病有关.
研究的目的:
- 要对ATB116表位池的Mtb特异性免疫反应进行表征.
- 了解这种免疫反应是如何通过结核病感染和治疗来调节的.
- 为开发新型结核病诊断和疫苗提供信息.
主要方法:
- 预期的观察性横截面研究设计.
- 招募健康捐赠者 (HD),结核病患者和结核病感染者 (TBI).
- 分析T细胞反应使用全血刺激与池,ELISA,流细胞计和多重检测.
主要成果:
- 特定于ATB116的IFN-γ反应与Mtb感染/疾病有显著的关联,并在结核病治疗期间减少.
- 流细胞计证实了与Mtb相关的CD4+T细胞反应,与TB相比,TBI中IFN-γ/IL-2和中央记忆T细胞的频率更高.
- 在结核病治疗后,CD4+和CD8+T细胞的反应都下降了,ATB116在结核病和TBI组中诱导了各种免疫因子.
结论:
- 该研究成功地描述了对Mtb池的免疫反应,突出了结核病治疗的调节.
- 这些发现有助于理解结核病免疫病原发生.
- 这些结果对于推进结核病疫苗设计和诊断策略具有重要意义.
相关概念视频
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis I
221
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
221
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis II
213
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
213
Pulmonary Tuberculosis III
312
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
312
Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489


